Charles F. Wagner Jr - Feb 1, 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Feb 1, 2022
Transactions value $
-$736,206
Form type
4
Date filed
2/3/2022, 03:29 PM
Next filing
Feb 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Award $0 +3.7K +10.63% $0.00 38.5K Feb 1, 2022 Direct F1
transaction VRTX Common Stock Award $0 +11.6K +30.21% $0.00 50.1K Feb 1, 2022 Direct F2
transaction VRTX Common Stock Award $0 +10.3K +20.48% $0.00 60.4K Feb 1, 2022 Direct F3
transaction VRTX Common Stock Sale -$736K -2.94K -4.88% $250.07 57.4K Feb 2, 2022 Direct F4, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents earned performance shares with respect to a performance stock unit award granted on 04/10/2019 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/01/2022 and the shares will vest on 02/24/2022.
F2 Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2021 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/01/2022 and the shares will vest in installments beginning on 02/17/2022.
F3 Restricted stock unit award that vests in installments beginning on 02/24/2023.
F4 Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1.
F5 Open market sales reported on this line occurred at a weighted average price of $250.07 (range $250.00 to $250.09).
F6 Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Remarks:

Exhibit 24 - Power of Attorney